Search Results - "Bissonnette R"

Reflections on chronic hand eczema - Authors' reply.

Authors: Bissonnette R Warren RB Pinter A et al.

Source: Lancet (London, England) [Lancet] 2025 Apr 12; Vol. 405 (10486), pp. 1229-1230.

Publication Type: Letter

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process

Author Index.

Source: International Journal of Rheumatic Diseases. Nov2024 Supplement 1, Vol. 27, p1-22. 22p.

Author Index.

Source: Australasian Journal of Dermatology. Jun2025 Supplement 1, Vol. 66, p109-113. 5p.

Author Index.

Source: Contact Dermatitis (01051873). Sep2024 Supplement 1, Vol. 91, p94-98. 5p.

Author Index 2022.

Source: Australasian Journal of Dermatology. May2022 Supplement S1, Vol. 63, p131-135. 5p.

Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

Authors: Potestio, Luca Patruno, Cataldo Ferrucci, Silvia Mariel et al.

Source: Dermatology & Therapy. Jul2026, Vol. 16 Issue 7, p3493-3511. 19p.

Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis).

Authors: Burlando, Martina Sacchelli, Lidia Bettacchi, Alberta et al.

Source: Journal of Clinical Medicine. Jun2026, Vol. 15 Issue 11, p4168. 14p.

Author Index.

Source: Australasian Journal of Dermatology. Apr2021 Supplement S1, Vol. 62, p143-148. 6p.

Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.

Authors: Magnolo, Nina Soung, Jennifer Frew, John et al.

Source: Dermatology & Therapy. Jul2026, Vol. 16 Issue 7, p3415-3429. 15p.

Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial.

Authors: Gooderham, Melinda Bunick, Christopher G. Yu, JiaDe et al.

Source: Dermatology & Therapy. Jul2026, Vol. 16 Issue 7, p3275-3283. 9p.

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Authors: Mendes-Bastos, Pedro Lobo, Inês Pires da Rosa, Gilberto et al.

Source: Dermatology & Therapy. Jul2026, Vol. 16 Issue 7, p3361-3383. 23p.

Management of Moderate‐to‐Severe Atopic Dermatitis With Systemic Medications: Review and Expert Commentary.

Authors: Adam, David N. Dhadwal, Gurbir Grewal, Parbeer et al.

Source: Dermatologic Therapy. 6/19/2026, Vol. 2026, p1-17. 17p.

Approach to the Assessment and Management of Adult Patients With Prurigo Nodularis: A Canadian Consensus.

Authors: Hong, H. Chih-ho Prajapati, Vimal H. Papp, Kim A. et al.

Source: Dermatologic Therapy. 5/8/2026, Vol. 2026, p1-8. 8p.

Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool.

Authors: Breakell, Thomas Neri, Paolo Staats, Léonie A. N. et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p300. 14p.

Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Authors: Avallone, Gianluca Bombelli, Andrea Gargiulo, Luigi et al.

Source: Dermatology & Therapy. Dec2025, Vol. 15 Issue 12, p3671-3688. 18p.

Risk of serious infection with JAK inhibitors in immune-mediated inflammatory skin diseases: a meta-analysis of randomized clinical trials.

Authors: Su, Xinhong Ou, Yushan Ruan, Shifan et al.

Source: Journal of Dermatological Treatment. Dec2025, Vol. 36 Issue 1, p1-8. 8p.

Author Index 2019.

Source: Australasian Journal of Dermatology. May2019 Supplement S1, Vol. 60, p107-110. 4p.

Burden and Etiopathogenesis of Chronic Hand Eczema: A Complex Interplay of Genes, Environment, and Exposures.

Authors: Molin S Yeung J Bissonnette R

Source: Journal of cutaneous medicine and surgery [J Cutan Med Surg] 2026 May-Jun; Vol. 30 (2_suppl), pp. 7S-14S. Date of Electronic Publication: 2026 Mar 17.

Publication Type: Journal Article; Review

Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 9614685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-7109 (Electronic) Linking ISSN: 12034754 NLM ISO Abbreviation: J Cutan Med Surg Subsets: MEDLINE

A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council.

Authors: Haag C Alexis A Aoki V et al.

Source: The British journal of dermatology [Br J Dermatol] 2024 Dec 23; Vol. 192 (1), pp. 135-143.

Publication Type: Journal Article; Practice Guideline; Consensus Statement

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials.

Authors: Bissonnette R Albreiki F Ehst BD et al.

Source: American journal of clinical dermatology [Am J Clin Dermatol] 2026 Jan; Vol. 27 (1), pp. 199-202. Date of Electronic Publication: 2025 Sep 26.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE